(Q39461881)

English

Second-line antiretroviral treatment successfully resuppresses drug-resistant HIV-1 after first-line failure: prospective cohort in Sub-Saharan Africa

scientific article published on 23 March 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 September 2017

Second-line antiretroviral treatment successfully resuppresses drug-resistant HIV-1 after first-line failure: prospective cohort in Sub-Saharan Africa (English)

1 reference

Europe PubMed Central

12 September 2017

anti-retroviral agent

0 references

Sub-Saharan Africa

0 references

4

object named as

Cissy Kityo

1 reference

Europe PubMed Central

12 September 2017

Tobias F Rinke de Wit

13

object named as

Tobias F Rinke de Wit

1 reference

Europe PubMed Central

12 September 2017

2

object named as

Raph L Hamers

1 reference

Europe PubMed Central

12 September 2017

6

object named as

Prudence Ive

1 reference

Europe PubMed Central

12 September 2017

Wendy S Stevens

11

object named as

Wendy S Stevens

1 reference

Europe PubMed Central

12 September 2017

Carole L Wallis

3

object named as

Carole L Wallis

1 reference

Europe PubMed Central

12 September 2017

Kim C E Sigaloff

1

object named as

Kim C E Sigaloff

1 reference

Europe PubMed Central

12 September 2017

Margaret Siwale

5

object named as

Margaret Siwale

1 reference

Europe PubMed Central

12 September 2017

Mariette E Botes

7

object named as

Mariette E Botes

1 reference

Europe PubMed Central

12 September 2017

10

object named as

Akin Osibogun

1 reference

Europe PubMed Central

12 September 2017

Michèle van Vugt

12

object named as

Michèle van Vugt

1 reference

Europe PubMed Central

12 September 2017

Kishor Mandaliya

8

object named as

Kishor Mandaliya

1 reference

Europe PubMed Central

12 September 2017

9

object named as

Maureen Wellington

1 reference

Europe PubMed Central

12 September 2017

PharmAccess African Studies to Evaluate Resistance (PASER)

14

object named as

PharmAccess African Studies to Evaluate Resistance (PASER)

1 reference

Europe PubMed Central

12 September 2017

language of work or name

0 references

publication date

23 March 2012

1 reference

Europe PubMed Central

12 September 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

12 September 2017

205

1 reference

Europe PubMed Central

12 September 2017

11

1 reference

Europe PubMed Central

12 September 2017

1739-1744

1 reference

Europe PubMed Central

12 September 2017

Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS261

21 January 2018

Incidence and predictors of death, retention, and switch to second-line regimens in antiretroviral- treated patients in sub-Saharan African Sites with comprehensive monitoring availability.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS261

21 January 2018

Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS261

21 January 2018

The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS261

21 January 2018

Web resources for HIV type 1 genotypic-resistance test interpretation

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS261

21 January 2018

Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS261

21 January 2018

High rates of survival, immune reconstitution, and virologic suppression on second-line antiretroviral therapy in South Africa

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS261

21 January 2018

Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS261

21 January 2018

HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS261

21 January 2018

Identifiers

10.1093/INFDIS/JIS261

1 reference

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

12 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39461881&oldid=1858786150"